Literature DB >> 17410185

Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.

E Kowarz1, T Burmeister, L Lo Nigro, M W J C Jansen, E Delabesse, T Klingebiel, Theo Dingermann, C Meyer, R Marschalek.   

Abstract

The human mixed lineage leukemia (MLL) gene is frequently involved in genetic rearrangements with more than 55 different translocation partner genes, all associated with acute leukemia. Reciprocal chromosomal translocations generate two MLL fusion alleles, where 5'- and 3'-portions of MLL are fused to gene segments of given fusion partners. In case of t(4;11) patients, about 80% of all patients exhibit both reciprocal fusion alleles, MLL.AF4 and AF4.MLL, respectively. By contrast, 20% of all t(4;11) patients seem to encode only the MLL.AF4 fusion allele. Here, we analyzed these 'MLL.AF4(+)/AF4.MLL(-)' patients at the genomic DNA level to unravel their genetic situation. Cryptic translocations and three-way translocations were found in this group of t(4;11) patients. Reciprocal MLL fusions with novel translocation partner genes, for example NF-KB1 and RABGAP1L, were identified and actively transcribed in leukemic cells. In other patients, the reciprocal 3'-MLL gene segment was fused out-of-frame to PBX1, ELF2, DSCAML1 and FXYD6. The latter rearrangements caused haploinsufficiency of genes that are normally expressed in hematopoietic cells. Finally, patients were identified that encode only solitary 3'-MLL gene segments on the reciprocal allele. Based on these data, we propose that all t(4;11) patients exhibit reciprocal MLL alleles, but due to the individual recombination events, provide different pathological disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410185     DOI: 10.1038/sj.leu.2404686

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  19 in total

1.  Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysis.

Authors:  V Mühlbacher; T Haferlach; W Kern; M Zenger; S Schnittger; C Haferlach
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

2.  RABGAP1L gene rearrangement resulting from a der(Y)t(Y;1)(q12;q25) in acute myeloid leukemia arising in a child with Klinefelter syndrome.

Authors:  Maria Cristina Roberti; Roberta La Starza; Cecilia Surace; Pietro Sirleto; Rita Maria Pinto; Valentina Pierini; Barbara Crescenzi; Cristina Mecucci; Adriano Angioni
Journal:  Virchows Arch       Date:  2009-01-28       Impact factor: 4.064

Review 3.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

4.  t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.

Authors:  Ashish R Kumar; Qing Yao; Quanzhi Li; Thien A Sam; John H Kersey
Journal:  Leuk Res       Date:  2010-09-25       Impact factor: 3.156

Review 5.  Mouse models of MLL leukemia: recapitulating the human disease.

Authors:  Thomas A Milne
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

6.  Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates HOXA9 Gene Expression in t(4;11) Leukemia Cells.

Authors:  Tiziana Fioretti; Armando Cevenini; Mariateresa Zanobio; Maddalena Raia; Daniela Sarnataro; Fabio Cattaneo; Rosario Ammendola; Gabriella Esposito
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

7.  Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion Protein.

Authors:  Samaneh Sabiani; Tim Geppert; Christian Engelbrecht; Eric Kowarz; Gisbert Schneider; Rolf Marschalek
Journal:  EBioMedicine       Date:  2015-04-16       Impact factor: 8.143

Review 8.  Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins.

Authors:  Erica Ballabio; Thomas A Milne
Journal:  Mol Cell Oncol       Date:  2014-10-29

9.  RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.

Authors:  Adam C Wilkinson; Erica Ballabio; Huimin Geng; Phillip North; Marta Tapia; Jon Kerry; Debabrata Biswas; Robert G Roeder; C David Allis; Ari Melnick; Marella F T R de Bruijn; Thomas A Milne
Journal:  Cell Rep       Date:  2013-01-24       Impact factor: 9.423

10.  Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.

Authors:  Erica Ballabio; Thomas A Milne
Journal:  Cancers (Basel)       Date:  2012-09-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.